Journal ArticleOPEN ACCESS

Scrotal Paget's Disease Associated With Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Apocrine Carcinoma With Complete Response to Paclitaxel, Trastuzumab, and Pertuzumab

  • Nowicka-Matus K
  • Salkus G
  • Sønderkær M
  • et al.
JCO Precision Oncology (2023) (7)
DOI: 10.1200/po.23.00173
4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Case report and literature review of targeted treatment of HER2-positive cutaneous apocrine carcinoma.

Cite

CITATION STYLE

APA

Nowicka-Matus, K., Salkus, G., Sønderkær, M., Søkilde Pedersen, I., Ernst, A., Kubik, M., … Ladekarl, M. (2023). Scrotal Paget’s Disease Associated With Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Apocrine Carcinoma With Complete Response to Paclitaxel, Trastuzumab, and Pertuzumab. JCO Precision Oncology, (7). https://doi.org/10.1200/po.23.00173

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free